An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study

Daniel C Malone, B. L. Carter, S. J. Billups, R. J. Valuck, D. J. Barnette, C. D. Sintek, G. J. Okano, S. Ellis, D. Covey, B. Mason, S. Jue, J. Carmichael, K. Guthrie, L. Sloboda, R. Dombrowski, D. R. Geraets, M. G. Amato

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Study Objective. To determine if clinical pharmacists could affect economic resource use and humanistic outcomes in an ambulatory, high-risk population. Design. Prospective, randomized, controlled study. Setting. Nine Veterans Affairs medical centers. Patients. Patients who were at high risk for medication-related problems. Intervention. Patients were randomized to usual medical care with input from a clinical pharmacist (intervention group) or just usual medical care (control group). Measurements and Main Results. Of 1054 patients enrolled, 523 were randomized to the intervention group and 531 to the control group. The number of clinic visits increased in the intervention group (p=0.003), but there was no difference in clinic costs. Mean increases in total health care costs were $1020 for the intervention group and $1313 for the control group (p=0.06). Conclusion. Including the cost of pharmacist interventions, overall health care expenditures were similar for patients randomized to see a clinical pharmacist versus usual medical care.

Original languageEnglish (US)
Pages (from-to)1149-1158
Number of pages10
JournalPharmacotherapy
Volume20
Issue number10 I
StatePublished - 2000
Externally publishedYes

Fingerprint

Veterans
Pharmacists
Multicenter Studies
Economics
Control Groups
Costs and Cost Analysis
Ambulatory Care
Health Expenditures
Health Care Costs
Delivery of Health Care
Population

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Malone, D. C., Carter, B. L., Billups, S. J., Valuck, R. J., Barnette, D. J., Sintek, C. D., ... Amato, M. G. (2000). An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study. Pharmacotherapy, 20(10 I), 1149-1158.

An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans : The IMPROVE study. / Malone, Daniel C; Carter, B. L.; Billups, S. J.; Valuck, R. J.; Barnette, D. J.; Sintek, C. D.; Okano, G. J.; Ellis, S.; Covey, D.; Mason, B.; Jue, S.; Carmichael, J.; Guthrie, K.; Sloboda, L.; Dombrowski, R.; Geraets, D. R.; Amato, M. G.

In: Pharmacotherapy, Vol. 20, No. 10 I, 2000, p. 1149-1158.

Research output: Contribution to journalArticle

Malone, DC, Carter, BL, Billups, SJ, Valuck, RJ, Barnette, DJ, Sintek, CD, Okano, GJ, Ellis, S, Covey, D, Mason, B, Jue, S, Carmichael, J, Guthrie, K, Sloboda, L, Dombrowski, R, Geraets, DR & Amato, MG 2000, 'An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study', Pharmacotherapy, vol. 20, no. 10 I, pp. 1149-1158.
Malone, Daniel C ; Carter, B. L. ; Billups, S. J. ; Valuck, R. J. ; Barnette, D. J. ; Sintek, C. D. ; Okano, G. J. ; Ellis, S. ; Covey, D. ; Mason, B. ; Jue, S. ; Carmichael, J. ; Guthrie, K. ; Sloboda, L. ; Dombrowski, R. ; Geraets, D. R. ; Amato, M. G. / An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans : The IMPROVE study. In: Pharmacotherapy. 2000 ; Vol. 20, No. 10 I. pp. 1149-1158.
@article{fde17f7afccd4c80b975a65f250e0ed8,
title = "An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study",
abstract = "Study Objective. To determine if clinical pharmacists could affect economic resource use and humanistic outcomes in an ambulatory, high-risk population. Design. Prospective, randomized, controlled study. Setting. Nine Veterans Affairs medical centers. Patients. Patients who were at high risk for medication-related problems. Intervention. Patients were randomized to usual medical care with input from a clinical pharmacist (intervention group) or just usual medical care (control group). Measurements and Main Results. Of 1054 patients enrolled, 523 were randomized to the intervention group and 531 to the control group. The number of clinic visits increased in the intervention group (p=0.003), but there was no difference in clinic costs. Mean increases in total health care costs were $1020 for the intervention group and $1313 for the control group (p=0.06). Conclusion. Including the cost of pharmacist interventions, overall health care expenditures were similar for patients randomized to see a clinical pharmacist versus usual medical care.",
author = "Malone, {Daniel C} and Carter, {B. L.} and Billups, {S. J.} and Valuck, {R. J.} and Barnette, {D. J.} and Sintek, {C. D.} and Okano, {G. J.} and S. Ellis and D. Covey and B. Mason and S. Jue and J. Carmichael and K. Guthrie and L. Sloboda and R. Dombrowski and Geraets, {D. R.} and Amato, {M. G.}",
year = "2000",
language = "English (US)",
volume = "20",
pages = "1149--1158",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "10 I",

}

TY - JOUR

T1 - An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans

T2 - The IMPROVE study

AU - Malone, Daniel C

AU - Carter, B. L.

AU - Billups, S. J.

AU - Valuck, R. J.

AU - Barnette, D. J.

AU - Sintek, C. D.

AU - Okano, G. J.

AU - Ellis, S.

AU - Covey, D.

AU - Mason, B.

AU - Jue, S.

AU - Carmichael, J.

AU - Guthrie, K.

AU - Sloboda, L.

AU - Dombrowski, R.

AU - Geraets, D. R.

AU - Amato, M. G.

PY - 2000

Y1 - 2000

N2 - Study Objective. To determine if clinical pharmacists could affect economic resource use and humanistic outcomes in an ambulatory, high-risk population. Design. Prospective, randomized, controlled study. Setting. Nine Veterans Affairs medical centers. Patients. Patients who were at high risk for medication-related problems. Intervention. Patients were randomized to usual medical care with input from a clinical pharmacist (intervention group) or just usual medical care (control group). Measurements and Main Results. Of 1054 patients enrolled, 523 were randomized to the intervention group and 531 to the control group. The number of clinic visits increased in the intervention group (p=0.003), but there was no difference in clinic costs. Mean increases in total health care costs were $1020 for the intervention group and $1313 for the control group (p=0.06). Conclusion. Including the cost of pharmacist interventions, overall health care expenditures were similar for patients randomized to see a clinical pharmacist versus usual medical care.

AB - Study Objective. To determine if clinical pharmacists could affect economic resource use and humanistic outcomes in an ambulatory, high-risk population. Design. Prospective, randomized, controlled study. Setting. Nine Veterans Affairs medical centers. Patients. Patients who were at high risk for medication-related problems. Intervention. Patients were randomized to usual medical care with input from a clinical pharmacist (intervention group) or just usual medical care (control group). Measurements and Main Results. Of 1054 patients enrolled, 523 were randomized to the intervention group and 531 to the control group. The number of clinic visits increased in the intervention group (p=0.003), but there was no difference in clinic costs. Mean increases in total health care costs were $1020 for the intervention group and $1313 for the control group (p=0.06). Conclusion. Including the cost of pharmacist interventions, overall health care expenditures were similar for patients randomized to see a clinical pharmacist versus usual medical care.

UR - http://www.scopus.com/inward/record.url?scp=0033779206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033779206&partnerID=8YFLogxK

M3 - Article

C2 - 11034037

AN - SCOPUS:0033779206

VL - 20

SP - 1149

EP - 1158

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 10 I

ER -